BC Innovations | May 23, 2017
Distillery Therapeutics

Cardiovascular

INDICATION: Cardiomyopathy Mouse studies suggest inhibiting FGF13 could help treat cardiomyopathy. In a mouse model of pressure overload-induced cardiac hypertrophy, cardiac-specific FGF13 knockout increased fractional shortening and decreased left ventricular hypertrophy, end-systolic and end-diastolic dimensions,...
BC Innovations | Jun 25, 2015
Distillery Techniques

Techniques: Fibroblast growth factor 13 (FGF13) translocations as predictive and diagnostic markers for genetic epilepsy and febrile seizures plus (GEFS+)

Biomarkers FGF13 Fibroblast growth factor 13 (FGF13) Duke University Medical Center...
Items per page:
1 - 2 of 2